Amarin Corp Plc (AMRN)

[Whalatane]

JL no problem admitting a mistake

My recall ...please correct ...from an earlier CC was that Amarin had about 20,000 patient years of study at the end of 2015. If 7,000 were in the trial for the first 6 mths of 2016 , that would add another 3,500 patient yrs to approx time of data lock.

How many patients yrs do you expect there to be by time of data lock ?

You know the limitations of JELIS . No need to repeat them . The link I provided , I believe provides a better over view of the considerations before the DMC

JMO
Kiwi